Galecto is Drug Discovery in Denmark that focus on progressive fibrotic disease business. Founded in 2011. They cover business area such as Galecto Inc, therapeutic, fibrosis, fibrotic and related disease, cancer, its initial focus, small-molecule inhibitor, its product candidate, severe fibrotic lung disease, IPF, non-alcoholic steatohepatitis, nash.
2011
( 13 years old in 2024 )
Progressive Fibrotic Disease
-
Ole Maaloes Vej 3
2200 Copenhagen North
Denmark
Private
Galecto Inctherapeuticfibrosisfibrotic and related diseasecancerits initial focussmall-molecule inhibitorits product candidatesevere fibrotic lung diseaseIPFnon-alcoholic steatohepatitisnash
* We use standard office opening hours in near Galecto's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Galecto is Drug Discovery business from Denmark that founded in 2011 (13 years old in 2024), Galecto business is focusing on Progressive Fibrotic Disease.
Galecto headquarter office and corporate office address is located in Ole Maaloes Vej 3 2200 Copenhagen North Denmark.
Galecto was founded in Denmark.
In 2024, Galecto is currently focus on progressive fibrotic disease sector.
Above is snippet of Google Trends for "progressive fibrotic disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Galecto, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
